National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer

Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko; Christopher P Childers

doi:10.1001/jamaoncol.2018.0340

National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer

JAMA Oncol. 2018 Jun 1;4(6):876-879. doi: 10.1001/jamaoncol.2018.0340.

Authors

Kimberly K Childers¹, Melinda Maggard-Gibbons², James Macinko^{3

4}, Christopher P Childers^{2

3}

Affiliations

¹ Center for Clinical Genetics and Genomics, Providence Health & Services Southern California, Los Angeles.
² Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles.
³ Department of Health Policy and Management, University of California Los Angeles Fielding School of Public Health, Los Angeles.
⁴ Department of Community Health Services, University of California Los Angeles Fielding School of Public Health, Los Angeles.

Abstract

This cross-sectional study describes the national distribution of genetic testing for hereditary cancer risk, identifies disparities, and assesses whether a gender gap exists

Publication types

Comparative Study

MeSH terms

Breast Neoplasms / epidemiology
Breast Neoplasms / genetics*
Breast Neoplasms, Male / epidemiology
Breast Neoplasms, Male / genetics
Cross-Sectional Studies
Female
Genetic Predisposition to Disease
Genetic Testing / statistics & numerical data*
Humans
Male
Medical History Taking
Neoplastic Syndromes, Hereditary / epidemiology
Neoplastic Syndromes, Hereditary / genetics*
Ovarian Neoplasms / epidemiology
Ovarian Neoplasms / genetics*
Procedures and Techniques Utilization
Risk Assessment
Self Report
Sex Distribution*
United States / epidemiology

Grants and funding

F32 HS025079/HS/AHRQ HHS/United States